X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Wockhardt with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs TEVA PHARMA (Israel) - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   TEVA PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
TEVA PHARMA
Dec-13
WOCKHARDT/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0122,872-   
Low Rs5322,495-   
Sales per share (Unadj.) Rs355.91,648.4-  
Earnings per share (Unadj.) Rs-60.3103.0-  
Cash flow per share (Unadj.) Rs-46.8236.2-  
Dividends per share (Unadj.) Rs0.0190.14-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs257.81,831.0-  
Shares outstanding (eoy) m110.63848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.21.6 133.2%   
Avg P/E ratio x-12.826.1 -49.1%  
P/CF ratio (eoy) x-16.511.4 -145.3%  
Price / Book Value ratio x3.01.5 204.2%  
Dividend payout %087.5 -0.0%   
Avg Mkt Cap Rs m85,3792,275,684 3.8%   
No. of employees `0006.344.9 13.9%   
Total wages/salary Rs m9,3710-   
Avg. sales/employee Rs Th6,295.031,100.4 20.2%   
Avg. wages/employee Rs Th1,498.30-   
Avg. net profit/employee Rs Th-1,066.31,942.8 -54.9%   
INCOME DATA
Net Sales Rs m39,3691,397,806 2.8%  
Other income Rs m1,2020-   
Total revenues Rs m40,5711,397,806 2.9%   
Gross profit Rs m18382,790 0.0%  
Depreciation Rs m1,495112,986 1.3%   
Interest Rs m2,55527,455 9.3%   
Profit before tax Rs m-2,830242,349 -1.2%   
Minority Interest Rs m01,101 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,582-159,089 2.3%   
Tax Rs m257-2,959 -8.7%   
Profit after tax Rs m-6,66987,320 -7.6%  
Gross profit margin %027.4 0.2%  
Effective tax rate %-9.1-1.2 743.9%   
Net profit margin %-16.96.2 -271.1%  
BALANCE SHEET DATA
Current assets Rs m33,796944,073 3.6%   
Current liabilities Rs m26,917823,312 3.3%   
Net working cap to sales %17.58.6 202.2%  
Current ratio x1.31.1 109.5%  
Inventory Days Days7991 87.4%  
Debtors Days Days8996 93.0%  
Net fixed assets Rs m39,664456,554 8.7%   
Share capital Rs m5533,441 16.1%   
"Free" reserves Rs m27,9680-   
Net worth Rs m28,5221,552,698 1.8%   
Long term debt Rs m21,731714,729 3.0%   
Total assets Rs m81,6203,194,435 2.6%  
Interest coverage x-0.19.8 -1.1%   
Debt to equity ratio x0.80.5 165.5%  
Sales to assets ratio x0.50.4 110.2%   
Return on assets %-5.03.6 -140.3%  
Return on equity %-23.45.6 -415.7%  
Return on capital %-7.74.9 -155.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,0190-   
CASH FLOW
From Operations Rs m684222,738 0.3%  
From Investments Rs m6,302-78,925 -8.0%  
From Financial Activity Rs m-7,695-267,189 2.9%  
Net Cashflow Rs m-664-123,376 0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.81 Rs / USD

Compare WOCKHARDT With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare WOCKHARDT With: TORRENT PHARMA  PANACEA BIOTECH  J.B.CHEMICALS  DR. REDDYS LAB  WYETH LTD  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views On News

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks (Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 18, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS